The Hunt for Urinary Biomarkers to Diagnose Kidney Cancer - Johns Hopkins Medicine
Biomarkers in drug discovery and development
Determinants of renal cell carcinoma invasion and metastatic competence | Nature Communications
Biomarkers in renal cell carcinoma: Are we there yet? - ScienceDirect
Biomarkers in renal cell carcinoma: Are we there yet? - ScienceDirect
Renal cell carcinoma: the search for a reliable biomarker - Farber - Translational Cancer Research
Exosomes as a Multicomponent Biomarker Platform in Cancer: Trends in Cancer
Frontiers | The Identification of Immunological Biomarkers in Kidney Cancers
Diseases | Free Full-Text | Proficient Novel Biomarkers Guide Early Detection of Acute Kidney Injury: A Review
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics | Communications Biology
Cabozantinib Slows Progression of Rare Kidney Cancer - NCI
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma - ScienceDirect
What is a Biomarker? | Lippincott NursingCenter
Biomarkers in renal cell carcinoma: Towards a more selective immune checkpoint inhibition - ScienceDirect
How are biomarkers used to treat cancer? | MD Anderson Cancer Center
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review: Molecular Therapy - Nucleic Acids
Renal cancer biomarkers: the promise of personalized care | BMC Medicine | Full Text
Comprehensive molecular characterization of clear cell renal cell carcinoma | Nature
Frontiers | Targeting the Tumor Microenvironment in Renal Cell Cancer Biology and Therapy
Extracellular vesicles as a source of prostate cancer biomarkers in liquid biopsies: a decade of research | British Journal of Cancer
Frontiers | IFI16 Can Be Used as a Biomarker for Diagnosis of Renal Cell Carcinoma and Prediction of Patient Survival
Frontiers | The Identification of Immunological Biomarkers in Kidney Cancers
A renal cell carcinoma tumorgraft platform to advance precision medicine - ScienceDirect
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
Kidney Cancer: Recent Advances and Future Directions | Journal of Clinical Oncology
Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma | Journal of Experimental & Clinical Cancer Research
